Answers are grounded in this paper and cite their sources.
HFmrEF represents an intermediate clinical phenotype between HFrEF and HFpEF, but shares a higher prevalence of CAD and CAD-related mortality risk with HFrEF.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Koh et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: